ロード中...
Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma
Immune checkpoint inhibitors have changed the landscape of classic cancer treatment. However, their use is associated with the emergence of new adverse events. An elderly man with rheumatoid arthritis was started on pembrolizumab for newly diagnosed advanced lung cancer. He subsequently developed he...
保存先:
| 出版年: | Intern Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Internal Medicine
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7205536/ https://ncbi.nlm.nih.gov/pubmed/32009093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3889-19 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|